ClinicalTrials.gg
RecruitingNCT06061224Updated Sep 29, 2023

The Influences of Early Mobilization on Myokines, Body Composition and Outcomes in ICU Septic Patients

An interventional study of early mobilization (physical therapy) in Sepsis, sponsored by Chang Gung Memorial Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2023-09-29.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2022, registered Sep 2023).
  • Started Jan 2022; still recruiting 4 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Sepsis by Chang Gung Memorial Hospital — 2 open to participants now, 2 under way, none of them phase 3. Sepsis · Chang Gung Memorial Hospital.

Started
2022
the only one that year
No phase
3 of 10
1 open now
Registered
9th of 10
by date

Among the 10 studies in Sepsis by Chang Gung Memorial Hospital, this one is the only one that started in 2022, is one of 3 with no phase, and was the 9th registered.

Sepsis

2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.

Browse Sepsis studies →

Open to participants now

2 of the 10 studies in Sepsis by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Sepsis by Chang Gung Memorial Hospital, or all of them as a file.
02

Study summary

the investigators' preliminary data revealed that early physical therapy in patients with sepsis in ICU could promote recovery of function (liver and kidney) and decrease the length of stay in hospitalization. The levels of plasma IL-6 and IL-10 were higher in non-survival group than in survival group. the investigators hypothesize that myokines and body composition parameters are related to the prognosis of sepsis.the investigators will investigate the influences of duration and intensity of early mobilization on myokines, body composition and outcomes of septic patients in intensive care. The proposed study can help precision medicine in the future.

Read the detailed description

The septic patients admitted to the intensive care unit (ICU) will be divided into three groups. One is non-PT group, with no physical treatment intervention (group 1), Early-PT group with physical treatment intervention started in ICU admission day 3 (group 2), and Delayed-PT with physical treatment intervention started after ICU admission day 3 (group 3). The grouping will be based on clinical indication for early mobilization (physical therapy) as below. The body composition data (of day 1, 3, 8) of the patients in the three groups will be measured, and the residual blood from day 1 and day 8 will be collected for detecting myokines.

03

Conditions studied

  • Sepsis

Browse trials for

Keywords

  • sepsis
  • early mobilization
  • myokines
  • body composition
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. Aadmission in ICU 2. Clinical diagnosis of sepsis

Exclusion criteria

Exclusion Criteria:

    1. Expired in 3-days 2. Cardiac stents or pacemakers 3. Airborne disease 4. Contact-transmitted disease
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
600 participants (estimated)

Study arms

  • No intervention
    non-PT group

    with no physical treatment intervention (group 1)

  • Experimental
    Early-PT group

    with physical treatment intervention started in ICU admission day 3 (group 2)

    Behavioral: early mobilization (physical therapy)

  • Experimental
    Delayed-PT

    with physical treatment intervention started after ICU admission day 3 (group 3)

    Behavioral: early mobilization (physical therapy)

Interventions

  • Behavioralearly mobilization (physical therapy)

    The investigators will consult rehabilitation department for Physical Therapy and patients will be grouped as clinically allocation. Protocols for consideration of initiation The timing is 72 hours after admission to ICU, early mobilization doses and duration is as the protocol of rehabilitation department

06

What researchers measure

Primary outcomes

  1. ICU mortality

    Status of survival or mortality at the time discharged from ICU

    Time frame: The day discharged from ICU, "through study completion, an average of 1 year".

  2. Hospital mortality

    Status of survival or mortality at the time discharged from hospital

    Time frame: The day discharged from hospital, "through study completion, an average of 1 year".

  3. 7-day mortality

    Status of survival or mortality at Day 7 during hospital stay

    Time frame: Day 7 after hospital admission

  4. 28-day mortality

    Status of survival or mortality at Day 28 during hospital stay

    Time frame: Day 28 after hospital admission

  5. 90-day mortality

    Status of survival or mortality at Day 90 during hospital stay

    Time frame: Day 90 after hospital admission

  6. ICU Days

    length of ICU stay

    Time frame: During hospitalization, "through study completion, an average of 1 year".

  7. Change of white blood cell between day 1 and day 8

    assessing the change of white blood cell count between day 1 and day 8

    Time frame: Day 1 and Day8 after ICU admission

  8. Ventilation days

    Total using days of mechanical ventilation

    Time frame: During hospitalization, "through study completion, an average of 1 year".

  9. Change of percentage of body fat between day 1 and day 8

    assessing the change of percentage of body fat between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)

    Time frame: Day 1 and Day 8 after ICU admission

  10. Change of total body water between day 1 and day 8

    assessing the change of total body water between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)

    Time frame: Day 1 and Day 8 after ICU admission

  11. Change of soft lean mass between day 1 and day 8

    assessing the change of soft lean mass between day 1 and day 8 by noninvasively Bio-electrical Impedance Analysis (BIA)

    Time frame: Day 1 and Day 8 after ICU admission

  12. Concentration of serum IL-6 change between day 1 and day 8

    assessing the change of IL-6 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

    Time frame: Day 1 and Day 8 after ICU admission

  13. Concentration of serum BDNF change between day 1 and day 8

    assessing the change of serum BDNF between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

    Time frame: Day 1 and Day 8 after ICU admission

  14. Concentration of serum IL-15 change between day 1 and day 8

    assessing the change of serum IL-15 between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

    Time frame: Day 1 and Day 8 after ICU admission

  15. Concentration of serum SPARC change between day 1 and day 8

    assessing the change of serum SPARC (secreted protein acidic and rich in cysteine) between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

    Time frame: Day 1 and Day 8 after ICU admission

  16. Concentration of serum Irisin change between day 1 and day 8

    assessing the change of serum Irisin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

    Time frame: Day 1 and Day 8 after ICU admission

  17. Concentration of serum Myostatin change between day 1 and day 8

    assessing the change of serum Myostatin between day 1 and day 8 by enzyme-linked immunosorbent assay (ELISA)

    Time frame: Day 1 and Day 8 after ICU admission

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Jun 2025, 41 months after the start.

Of 303 non-industry interventional studies with no phase under Sepsis, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 41 months is above that.

Counting every sponsor, half of 326 studies reached it within 22 months; a quarter within 11 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 5, 2023
First posted
Sep 29, 2023
StartActual
Jan 1, 2022
Primary completionEst.
Jun 30, 2025
CompletionEst.
Sep 30, 2025
Last update
Sep 29, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06061224
Responsible party
Sponsor
First posted
Sep 29, 2023
Start date
Jan 1, 2022
Primary completion
Jun 30, 2025 (estimated)
Completion
Sep 30, 2025 (estimated)
Last update
Sep 29, 2023

Study contacts

FANG WEN-FENG
Contact
wenfengfang@yahoo.com.tw
+886 7 731 7123 ext. 8775
FANG WEN-FENG
principal investigator · Chang Gung Memorial Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion